Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Richard A. de Vries"'
Autor:
Petrousjka van den Tol, Karin Nielsen, Aukje A. J. M. van Tilborg, Hester J. Scheffer, Martijn R. Meijerink, Richard A de Vries, Marleen C. A. M. Melenhorst, Karin M. J. van Nieuwkerk
Publikováno v:
Scheffer, H J, Melenhorst, M C A M, van Tilborg, A A J M, Nielsen, K, van Nieuwkerk, C M J, de Vries, R A, van den Tol, M P & Meijerink, M R 2015, ' Percutaneous Irreversible Electroporation of a Large Centrally Located Hepatocellular Adenoma in a Woman with a Pregnancy Wish ', CardioVascular and Interventional Radiology, vol. 38, no. 4, pp. 1031-1035 . https://doi.org/10.1007/s00270-014-1041-8
CardioVascular and Interventional Radiology, 38(4), 1031-1035. Springer Verlag
CardioVascular and Interventional Radiology, 38(4), 1031-1035. Springer Verlag
Irreversible electroporation (IRE) is a novel image-guided ablation technique that is rapidly gaining popularity in the treatment of malignant liver tumors located near large vessels or bile ducts. We describe a 28-year-old female patient with a 5 cm
Autor:
Nicole M A Nagtzaam, Herman van Dekken, Ewout W. Steyerberg, Caspar W. N. Looman, Ernst J. Kuipers, Richard A. de Vries, Annemarie C. de Vries, Jelle Haringsma, Frank ter Borg, Lisette G. Capelle
Publikováno v:
Helicobacter, 14(6), 596-604. Wiley-Blackwell Publishing Ltd
Helicobacter, 14(6), 596-604
Helicobacter, 14(6), 596-604
Background: Serological screening for gastric cancer (GC) may reduce mortality. However, optimal serum markers for advanced gastric precursor lesions are lacking. Aim: To evaluate in a case-control study whether serum leptin levels correlate with int
Autor:
Harry L.A. Janssen, Halis Simsek, Guido Gerken, Elke Verhey, Maria Buti, Bettina E. Hansen, Richard A. de Vries, Hajo J. Flink, Sachithanandan Sharmila, George Kitis, Erik H.C.J. Buster, E. Jenny Heathcote
Publikováno v:
American Journal of Gastroenterology, 104(10), 2449-2457. Springer Nature
OBJECTIVES: Treatment with pegylated interferon (PEG-IFN) alpha-2b results in hepatitis B e antigen (HBeAg) loss in 36% of patients at 6 months post treatment. The aim of this study was to determine whether a long-term response to PEG-IFN is dependen
Autor:
Harry L.A. Janssen, Helmer Ring-Larsen, Fiebo J.W. ten Kate, Nikolai V. Naoumov, P. Honkoop, Vicente Carreño, Patrick Marcellin, Jan van Hattum, Rudolf A. Heijtink, Antonio Craxì, Richard A. de Vries, Peter Michielsen, George Kitis, Solko W. Schalm, Wim C. J. Hop, G. Gerken
Publikováno v:
Hepatology. 30:238-243
Interferon alfa (IFN-alpha) is the primary treatment for chronic hepatitis B. The standard duration of IFN-alpha therapy is considered 16 weeks; however, the optimal treatment length is still poorly defined. We evaluated the efficacy and acceptabilit
Autor:
Marjo J. Kerbert, Janny W. den Ouden, Solko W. Scalm, Rene A. A. van Zanten, Hans H. van Lijf, Henk R. van Buuren, Fiebo J.W. ten Kate, Frank H. J. Wolghagen, Richard A. de Vries, Wim C. J. Hop, Egbert W. van der Hoek, Adelbert M. Smit, Gerard P. van Berge-Henegouwen, Hubert J. F. van Hoogstraten
Publikováno v:
Journal of Hepatology, 29, 736-742. Elsevier
Journal of hepatology, 29(5), 736-742. Elsevier
Journal of hepatology, 29(5), 736-742. Elsevier
Treatment with ursodeoxycholic acid has been shown to decrease the rate of disease progression in patients with primary biliary cirrhosis, although the effect is modest. Since primary biliary cirrhosis has many features of an autoimmune disorder, imm
Autor:
Peter Houben, Nancy A.M. Van Ooteghem, J.M. Vrolijk, Peter D. Siersema, Bart van Hoek, Rob J. Lieverse, Karel J. van Erpecum, Hanneke van Soest, Ger H. Koek, Greet J. Boland, Marguerite E.I. Schipper, Richard A. de Vries, Peter J. van der Schaar, Joost P.H. Drenth, Annet van der Sluys Veer
Publikováno v:
Digestive and Liver Disease, 42, 7, pp. 496-502
Digestive and Liver Disease, 42, 496-502
Digestive and Liver Disease, 42(7), 496-502
Digestive and Liver Disease, 42(7), 496-502. Elsevier Science
Digestive and Liver Disease, 42, 496-502
Digestive and Liver Disease, 42(7), 496-502
Digestive and Liver Disease, 42(7), 496-502. Elsevier Science
Contains fulltext : 89730.pdf (Publisher’s version ) (Closed access) BACKGROUND: Benefit of adding amantadine to antiviral therapy for hepatitis C is controversial. AIMS: We aimed to examine whether such policy enhances sustained viral response in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde32cd623e5b2aadcd5f1b6414e3213
https://hdl.handle.net/1887/100153
https://hdl.handle.net/1887/100153
Autor:
Annemarie C, de Vries, Jelle, Haringsma, Richard A, de Vries, Frank, Ter Borg, Nicole C T, van Grieken, Gerrit A, Meijer, Herman, van Dekken, Ernst J, Kuipers
Publikováno v:
Helicobacter. 15(4)
Endoscopic surveillance of pre-malignant gastric lesions may add to gastric cancer prevention. However, the appropriate biopsy regimen for optimal detection of the most advanced lesions remains to be determined. Therefore, we evaluated the yield of e
Autor:
Hanneke van Soest, K.F. Kok, Martijn G.H. van Oijen, Antonius E. van Herwaarden, Greet J. Boland, Richard A. de Vries, Thomas Berg, Joost P.H. Drenth, Juliane Halangk
Publikováno v:
European Journal of Gastroenterology & Hepatology, 22, 808-12
European journal of gastroenterology & hepatology, 22(7), 808-812. Lippincott Williams and Wilkins
European Journal of Gastroenterology & Hepatology, 22, 7, pp. 808-12
European journal of gastroenterology & hepatology, 22(7), 808-812. Lippincott Williams and Wilkins
European Journal of Gastroenterology & Hepatology, 22, 7, pp. 808-12
Background The role of heterozygosity for alpha-1 antitrypsin (A1AT) alleles in patients with chronic hepatitis C virus (HCV) is unclear. There is limited evidence to suggest that there is an increased prevalence of heterozygous A1AT carriers in HCV,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f498716385c845e09bb1618a15e84f9
http://hdl.handle.net/2066/88034
http://hdl.handle.net/2066/88034
Autor:
Annemarie C. de Vries, Herman van Dekken, Richard A. de Vries, Jelle Haringsma, Ernst J. Kuipers, Nicole M A Nagtzaam, Ewout W. Steyerberg, Frank ter Borg
Publikováno v:
Gastrointestinal Endoscopy, 70(1), 18-25. Mosby Inc.
Background: Surveillance of intestinal metaplasia (IM) of the gastric mucosa Should be limited to patients at high risk of gastric cancer. Patients with extensive IM are at increased cancer risk; however, the intragastric extent of IM is usually unkn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe3dd10d74112e08612e0e5cf6916ef
https://pure.eur.nl/en/publications/5cb39c00-92d9-4503-b6d8-48d92f7c4f03
https://pure.eur.nl/en/publications/5cb39c00-92d9-4503-b6d8-48d92f7c4f03
Autor:
Edith M M, Kuiper, Bettina E, Hansen, Richard A, de Vries, Jannie W, den Ouden-Muller, Theo J M, van Ditzhuijsen, Els B, Haagsma, Martin H M G, Houben, Ben J M, Witteman, Karel J, van Erpecum, Henk R, van Buuren, J, Lambert
Publikováno v:
Gastroenterology, 136(4), 1281-7. Elsevier Saunders
Gastroenterology, 136, 1281-7
Gastroenterology, 136(4), 1281-1287. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 136, 4, pp. 1281-7
Gastroenterology, 136(4), 1281-1287. W.B. Saunders
Gastroenterology, 136, 1281-7
Gastroenterology, 136(4), 1281-1287. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 136, 4, pp. 1281-7
Gastroenterology, 136(4), 1281-1287. W.B. Saunders
Contains fulltext : 80309.pdf (Publisher’s version ) (Closed access) BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) improves laboratory liver test results in patients with primary biliary cirrhosis (PBC). Few studies have assessed the prognostic si